These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 35583650)

  • 21. Size-Controlled Iron Oxide Nanoplatforms with Lipidoid-Stabilized Shells for Efficient Magnetic Resonance Imaging-Trackable Lymph Node Targeting and High-Capacity Biomolecule Display.
    Clauson RM; Chen M; Scheetz LM; Berg B; Chertok B
    ACS Appl Mater Interfaces; 2018 Jun; 10(24):20281-20295. PubMed ID: 29883088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of magnetic nanoparticles in biomedical applications.
    Naqvi S; Samim M; Dinda AK; Iqbal Z; Telagoanker S; Ahmed FJ; Maitra A
    Recent Pat Drug Deliv Formul; 2009 Jun; 3(2):153-61. PubMed ID: 19519575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies.
    Soetaert F; Korangath P; Serantes D; Fiering S; Ivkov R
    Adv Drug Deliv Rev; 2020; 163-164():65-83. PubMed ID: 32603814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. External magnetic fields affect the biological impacts of superparamagnetic iron nanoparticles.
    Shanehsazzadeh S; Lahooti A; Hajipour MJ; Ghavami M; Azhdarzadeh M
    Colloids Surf B Biointerfaces; 2015 Dec; 136():1107-12. PubMed ID: 26613856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic iron oxide nanoparticles as drug carriers: clinical relevance.
    El-Boubbou K
    Nanomedicine (Lond); 2018 Apr; 13(8):953-971. PubMed ID: 29376469
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Ognjanović M; Radović M; Mirković M; Prijović Ž; Puerto Morales MD; Čeh M; Vranješ-Đurić S; Antić B
    ACS Appl Mater Interfaces; 2019 Nov; 11(44):41109-41117. PubMed ID: 31610125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in Atherosclerosis Theranostics Harnessing Iron Oxide-Based Nanoparticles.
    Wang S; He H; Mao Y; Zhang Y; Gu N
    Adv Sci (Weinh); 2024 May; 11(17):e2308298. PubMed ID: 38368274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stabilization and functionalization of iron oxide nanoparticles for biomedical applications.
    Amstad E; Textor M; Reimhult E
    Nanoscale; 2011 Jul; 3(7):2819-43. PubMed ID: 21629911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surface engineering of magnetic iron oxide nanoparticles by polymer grafting: synthesis progress and biomedical applications.
    Hou Z; Liu Y; Xu J; Zhu J
    Nanoscale; 2020 Jul; 12(28):14957-14975. PubMed ID: 32648868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Organ-specific toxicity of magnetic iron oxide-based nanoparticles.
    Chrishtop VV; Mironov VA; Prilepskii AY; Nikonorova VG; Vinogradov VV
    Nanotoxicology; 2021 Mar; 15(2):167-204. PubMed ID: 33216662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicity, toxicokinetics and biodistribution of dextran stabilized Iron oxide Nanoparticles for biomedical applications.
    Remya NS; Syama S; Sabareeswaran A; Mohanan PV
    Int J Pharm; 2016 Sep; 511(1):586-598. PubMed ID: 27451271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iron Oxide Nanoparticles: Physicochemical Characteristics and Historical Developments to Commercialization for Potential Technological Applications.
    Etemadi H; Buchanan JK; Kandile NG; Plieger PG
    ACS Biomater Sci Eng; 2021 Dec; 7(12):5432-5450. PubMed ID: 34786932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Application and advancement of magnetic iron-oxide nanoparticles in tumor-targeted therapy].
    Chen Y; Chen BA
    Chin J Cancer; 2010 Jan; 29(1):125-8. PubMed ID: 20038325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progress and prospects of magnetic iron oxide nanoparticles in biomedical applications: A review.
    Elahi N; Rizwan M
    Artif Organs; 2021 Nov; 45(11):1272-1299. PubMed ID: 34245037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications.
    Gupta AK; Gupta M
    Biomaterials; 2005 Jun; 26(18):3995-4021. PubMed ID: 15626447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and characterization of superparamagnetic iron oxide nanoparticles for magnetically guided drug delivery.
    Kumar P; Agnihotri S; Roy I
    Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):43-46. PubMed ID: 30880956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioconjugation and Fluorescence Labeling of Iron Oxide Nanoparticles Grafted with Bromomaleimide-Terminal Polymers.
    Qiao R; Esser L; Fu C; Zhang C; Hu J; Ramírez-Arcía P; Li Y; Quinn JF; Whittaker MR; Whittaker AK; Davis TP
    Biomacromolecules; 2018 Nov; 19(11):4423-4429. PubMed ID: 30350948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PEG-mediated synthesis of highly dispersive multifunctional superparamagnetic nanoparticles: their physicochemical properties and function in vivo.
    Sun C; Du K; Fang C; Bhattarai N; Veiseh O; Kievit F; Stephen Z; Lee D; Ellenbogen RG; Ratner B; Zhang M
    ACS Nano; 2010 Apr; 4(4):2402-10. PubMed ID: 20232826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tailored functionalization of iron oxide nanoparticles for MRI, drug delivery, magnetic separation and immobilization of biosubstances.
    Hola K; Markova Z; Zoppellaro G; Tucek J; Zboril R
    Biotechnol Adv; 2015 Nov; 33(6 Pt 2):1162-76. PubMed ID: 25689073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iron oxide nanoparticles based magnetic luminescent quantum dots (MQDs) synthesis and biomedical/biological applications: A review.
    Tufani A; Qureshi A; Niazi JH
    Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111545. PubMed ID: 33255097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.